Unleashing the clinical power of T cells: CD19/CD3 bi-specific T cell engager (BiTE) antibody construct blinatumomab as a potential therapy - Zimmerman, Zachary; Maniar, Tapan; Nagorsen, Dirk (International immunology, 2015)
Gesehen am 19.11.2018